Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin

• Published in: Molecular metabolism (Germany) 2021-11, Vol.53, p.101309-101309, Article 101309
• Main Authors: Byles, Vanessa, Cormerais, Yann, Kalafut, Krystle, Barrera, Victor, Hughes Hallett, James E., Sui, Shannan Ho, Asara, John M., Adams, Christopher M., Hoxhaj, Gerta, Ben-Sahra, Issam, Manning, Brendan D.
• Format: Article
• Language: English
• Subjects: Activating Transcription Factor 4 - deficiency; Activating Transcription Factor 4 - metabolism; Animal Feed; Animals; ATF4; Feeding; Feeding Behavior; Insulin; Insulin - metabolism; Liver; Liver - metabolism; Mechanistic Target of Rapamycin Complex 1 - metabolism; Methionine metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; mTORC1; Original; Signal Transduction
• ISSN: 2212-8778; 2212-8778
• DOI: 10.1016/j.molmet.2021.101309

The mechanistic target of rapamycin complex 1 (mTORC1) is dynamically regulated by fasting and feeding cycles in the liver to promote protein and lipid synthesis while suppressing autophagy. However, beyond these functions, the metabolic response of the liver to feeding and insulin signaling orchestrated by mTORC1 remains poorly defined. Here, we determine whether ATF4, a stress responsive transcription factor recently found to be independently regulated by mTORC1 signaling in proliferating cells, is responsive to hepatic mTORC1 signaling to alter hepatocyte metabolism. ATF4 protein levels and expression of canonical gene targets were analyzed in the liver following fasting and physiological feeding in the presence or absence of the mTORC1 inhibitor, rapamycin. Primary hepatocytes from wild-type or liver-specific Atf4 knockout (LAtf4KO) mice were used to characterize the effects of insulin-stimulated mTORC1-ATF4 function on hepatocyte gene expression and metabolism. Both unbiased steady-state metabolomics and stable-isotope tracing methods were employed to define mTORC1 and ATF4-dependent metabolic changes. RNA-sequencing was used to determine global changes in feeding-induced transcripts in the livers of wild-type versus LAtf4KO mice. We demonstrate that ATF4 and its metabolic gene targets are stimulated by mTORC1 signaling in the liver, in a hepatocyte-intrinsic manner by insulin in response to feeding. While we demonstrate that de novo purine and pyrimidine synthesis is stimulated by insulin through mTORC1 signaling in primary hepatocytes, this regulation was independent of ATF4. Metabolomics and metabolite tracing studies revealed that insulin-mTORC1-ATF4 signaling stimulates pathways of nonessential amino acid synthesis in primary hepatocytes, including those of alanine, aspartate, methionine, and cysteine, but not serine. The results demonstrate that ATF4 is a novel metabolic effector of mTORC1 in the liver, extending the molecular consequences of feeding and insulin-induced mTORC1 signaling in this key metabolic tissue to the control of amino acid metabolism. •Hepatic mTORC1 activates ATF4 and its gene targets with physiological feeding.•Hepatic ATF4 induces genes involved in amino acid metabolism with feeding.•Insulin-mTORC1 signaling stimulates de novo nucleotide synthesis in hepatocytes.•mTORC1-ATF4 induces hepatocyte synthesis of alanine and aspartate, but not serine.•mTORC1-ATF4 stimulates flux into the methionine cycle and trans-sulfuration pa